Clinical Trials Browser

Phase 1 × Advanced Cancer × prexasertib × Clear all

NCT02778126 2019-08-01

A Study of Prexasertib (LY2606368) in Participants With Advanced Cancer

Phase 1 Completed

Advanced Cancer